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Epidemiological studies may be helpful for increasing our understanding of IDDM as well as being important sources for genetic studies. The Danish population is approximately 5.2 million; the prevalence of IDDM in Denmark is 0.4 % [9] and the mean incidencerates in Danish representative subpopulations in the age groups 0±29 years and over 29 years is 13.2 and 8.2 × 100 000 ±1 × year
±1
, respectively [11, 12] . A recent Danish nationwide population-based study of the familial aggregation of IDDM [13] found that diabetic offspring of IDDM parents were significantly more likely to have an affected father than an affected mother. Similar observations have been made in other studies [14±17] . In order to avoid ascertainment bias, the optimal study design, however, is a follow-up design with calculation of the cumulative IDDM risk (number of IDDM cases per total number of offspring-years at risk) in offspring of families ascertained through IDDM in the parental generation. A recent Finnish nationwide register-based study [6] found that offspring of IDDM affected fathers had a higher IDDM risk compared to offspring of IDDM affected mothers. Furthermore, a number of previous non-Scandinavian studies [2±5, 18] in which the probands were ascertained from the parental generation supported this gender difference in recurrence risk of IDDM in offspring. However, most of these studies were performed on small and selected populations. From two recent studies on different patient populations from the Joslin Diabetes Clinic, relationships between parental age of IDDM onset and the recurrence risk in their offspring was reported [4, 5] . It was also shown that the risk of IDDM in offspring of IDDM mothers was significantly increased in offspring born to mothers younger than 25 years of age compared to older mothers [4, 5, 19] . Other studies have shown that the IDDM recurrence risk in offspring was influenced by gender and birth order of the offspring [6, 14, 17] . The aim of the present study was to assess the recurrence risk of IDDM in 2826 offspring of a population of 2726 adult Danish IDDM patients, and to identify and characterise parental-and offspring-related biological variables that might influence the recurrence risk of IDDM. The present study is a non-concurrent prospective study, i. e. the outcomes of interest occurred in the past [20] .
Subjects and methods
Background population. In Denmark an annual census is performed [21], thereby allowing an exact demographic description of the population. The populations of the five counties: Copenhagen, Frederiksborg, Roskilde, Vest-Sjñlland and Storstrùm, respectively, were chosen as a background population. These areas are inhabited by a total of 1.725 million people, i. e. 33 % of the Danish population.
Study population and methods. No central registration of patients with IDDM takes place in Denmark. In the present study we intended to identify all Caucasian IDDM patients of the survey area aged between 20 and 65 years on continuous insulin treatment since the time of diagnosis.
The Steno Diabetes Center (SDC) is an integrated part of the public Danish Health Care serving Copenhagen County as a primary and secondary referral centre for IDDM. From previous incidence studies [11, 12] of IDDM in Copenhagen County we know that only about 1 % of IDDM cases are not referred to the SDC, either at presentation or within a few weeks thereafter, for lifelong outpatient follow-up. This referral pattern has not changed, with the exception that about half the cases of newly diagnosed IDDM patients below the age of 15 years during the last decade have been referred to the department of paediatrics at Glostrup Hospital. By the age of 18 years these patients are referred to the SDC for follow-up.
Outside Copenhagen County the referral pattern is different; all hospital-based regional diabetes care units participated and all 701 general practitioners (GPs) were asked to identify their IDDM patients fulfilling the inclusion criteria of the study. Seventy-two percent of the GPs co-operated and identified 118 patients, of these 71 were included in the study.
Extrapolating from the 118 patients identified through the GPs we could calculate that only 165 (5 % of the total) patients in total fulfilling the inclusion criteria were followed by GPs and not by hospital-based diabetes care units, since the nonparticipating GPs did not differ from the participating GPs in their way of running the clinics and none are known to have a special interest in diabetes care. That this does not significantly influence the study is obvious. This may be further supported by the fact that the prevalence of familial IDDM was similar in hospital-identified (17.5 %) and GP-identified cases (18.2 %).
There is no other completely independent source for ascertainment validation appropriate for this study. The coding of IDDM diagnoses is contaminated with insulin-treated non-insulin-dependent diabetic patients in the National Central Registry of Discharge Diagnoses, and for the same reason insulin prescriptions do not provide valid information either.
Information on age at IDDM onset and insulin treatment was obtained from the medical records of the identified IDDM patients aged between 20 and 65 years. Those fulfilling our inclusion criteria were asked to complete a questionnaire. If no response was received a second questionnaire was sent. If questionnaires were returned incomplete, further information was obtained by telephone interview. The questionnaires requested information on: Age and sex of all biological offspring and if any of these were deceased and/or had been diagnosed with IDDM, their age at the time of that event.
In total 3408 (1852 males and 1556 females; p < 0.001) potential probands were identified. Of these, 2824 (82.9 %) supplied information for the study. Ninety-eight (2.9 %) patients gave incomplete information and were not included in the analyses. Of the 3408 patients identified for the study, 2726 probands (1422 males and 1304 females; p = 0.1) were included. Hence, the final participation rate was 80 %. However, female probands had a higher participation rate than male probands (84 vs 77 %; p < 0.01).
The female probands of the study population with offspring were pregnant during the period 1953±1995. In Denmark obstetric care for pregnant diabetic women is centralised and has followed national guidelines since 1946 [22, 23] .
The study was approved by the ethics committee of the Counties of Copenhagen, Roskilde, Frederiksborg, Vest-Sjñl-land and Storstrùm and by the Danish Registertilsyn. Informed consent was obtained from all included probands.
Statistical analyses.
A database of the 2726 included probands and their 2826 offspring was established using the PARADOX (version 4.5) software package (Borland, Scotts Valley, CA). Calculations and statistical analyses of the data were performed using the MICROSOFT EXCEL (version 7.0) (Microsoft Corporation, Redmond, WA) and the BMDP DYNAMIC (version 7.0). Demographic data are expressed as mean ± SD. The two-tailed Student's t-test was used to evaluate statistical differences in means for continuous variables. For independent categorical variables, the chi-square test was used to compare proportions. The recurrence risks of IDDM in offspring were calculated for each age (expressed in years) as the number of cases per total number of offspring-years at risk using a standard life-table method ± SE. The cumulative risk was calculated by addition of the risk values from the time of birth up to several different ages. Statistical comparisons of life-tables were performed using the Mantel-Cox test for estimating significance. Cox proportional hazards stepwise regression analyses were used to investigate the significance of several variables on cumulative recurrence risk. Relative risks (RR) and 95 % confidence intervals (CI) were estimated when adjusting for covariates. The level of statistical significance was chosen as 0.05 (two-tailed). When multiple comparisons were performed between groups, p-values were corrected by the number of comparisons (p c ).
Results
The characteristics of the 2726 probands are summarised in Table 1 . The mean age at the time of diagnosis in female and male probands, respectively was 15.5 ± 7.7 and 17.2 ± 7.9 years (p c < 0.001) not different from the corresponding median ages of IDDM onset of 17 years and 15 years. The IDDM duration in the probands was similar in males and females while the mean age at the time of offspring birth was significantly higher in male probands (p c < 0.001). This difference in mean age at offspring birth was however, only significant in probands diagnosed with IDDM before offspring birth (Table 1) , probably due to the low number of deliveries in the other group. The 2726 probands had a total of 2826 offspring with no significant difference in the mean number of paternal, as opposed to maternal offspring (p c > 0.4). Five hundred and sixty-eight male probands (40 %) and 533 female probands (41 %) had no offspring; however, stratifying the probands according to current age revealed that 79 % of the probands aged above 40 years had at least one offspring with no significant difference between male and female probands (data not shown). Among these probands the mean number of offspring per male and female proband was 2.0 and 1.8, respectively (p = 0.3).
Forty-four of the 1422 male probands (3.1 %) and 22 of the 1304 female probands (1.7 %) had at least 1 IDDM affected offspring (p = 0.02). One male proband had 3 offspring with IDDM and another male proband had 2 IDDM affected offspring.
It was not possible to obtain information on current age in 64 of the 2826 offspring (2.3 %). Table 2 characterises the 2380 (84 %) offspring (1209 males, 1161 females, 10 of unknown gender) of probands diagnosed with IDDM before the time of delivery of the offspring in question. Table 2 characterises the 382 (14 %) offspring (206 males, 173 females, 3 of unknown gender) of probands diagnosed after offspring birth. In both groups there were no significant gender differences between the diabetic offspring, either in offspring of male nor of female probands. A significant positive birth order effect on IDDM prevalence was seen in offspring of female probands diagnosed with IDDM prior to offspring birth (p c < 0.001). The number of offspring per proband was significantly reduced in offspring of both male and female probands diagnosed with IDDM before the birth of the first offspring compared to probands diagnosed with IDDM after the birth of all their offspring (0.8 vs 1.9 in females; p < 0.0001 and 1.0 vs 1.7 in males; p = 0.005). No difference was found in mean current age between the two groups of probands diagnosed with IDDM before, rather than after offspring birth (45.4 ± 10.1 vs 45.5 ± 10.5 years; p > 0.5). The cumulative recurrence risk of IDDM in offspring was calculated. Sixty-nine of the 2826 offspring (2.4 %) were diagnosed with IDDM and only one of those was diagnosed after age 30 years (male offspring of female proband, age at onset 33 years). In offspring of all probands the cumulative IDDM risk was 4.7 ± 0.7 % up to age 30 years and distinguishing between offspring of males and females, the risk was 5.7 ± 0.9 and 3.4 ± 1.0 %, respectively, up to age 30 years (RR = 1.92, 95 % CI 1.13±3.25; p = 0.01). In the offspring whose parents were diagnosed with IDDM before offspring birth, IDDM had developed in 42 paternal offspring during 18 866 offspring observation years and in 13 maternal offspring during 14 193 offspring observation years. In this subpopulation the cumulative recurrence risks up to age 30 years ( Fig. 1) in offspring of males rather than females were 5.7 ± 0.9 and 2.3 ± 0.6 %, respectively (RR = 2.40, 95 % CI 1.30±4.47; p = 0.004). In the offspring of probands diagnosed with IDDM after off- All p c -values > 0.05 for comparisons between paternal in respect to maternal offspring spring birth, IDDM had developed in 5 offspring of males and 9 offspring of females during 3616 and 5534 offspring observation years, respectively. The cumulative recurrence risks up to age 30 years were identical, i. e. 4.9 ± 2.2 and 4.9 ± 1.8 % in offspring of male and female probands, respectively (p > 0.9). In offspring of female probands we found a relative IDDM risk of 1.75, 95 % CI 0.72±4.25 in offspring of mothers diagnosed with IDDM after offspring birth as compared to offspring of mothers diagnosed with IDDM prior to offspring birth. This difference, however, was not significant (p = 0.2) with the available number of maternal offspring IDDM cases. In paternal offspring the corresponding relative risk was 1.21, 95 % CI 0.61±2.64; p = 0.7. In order to avoid a possible confounding from differences in parental IDDM status at the time of pregnancy, we have chosen to restrict the following analyses to the 2380 offspring whose parents were all diagnosed with IDDM before offspring birth. The incidence rates of IDDM in offspring, according to the probands age of IDDM onset, are shown in Table 3 . These data suggest that offspring of male probands diagnosed at an early age have an increased IDDM recurrence risk. A possible influence of parental age of IDDM onset on the cumulative IDDM recurrence risk in offspring was evaluated by calculation of this risk according to the median age of IDDM onset in male and female probands of 17 and 15 years, respectively. When we use these cut-off points in the analyses, the numbers of offspring observation-years (the denominator of the life-table analyses) in the subgroups are of the same magnitude giving the best power for the detection of differences between the subgroups. This analysis revealed (Fig. 2) that the cumulative IDDM risk up to age 30 years in offspring of male probands diagnosed up to or later than 17 years was 8.5 ± 1.8 and 3.6 ± 1.0 %; RR = 2.27, 95 % CI 1.21±4.25; p = 0.006. In offspring of female probands diagnosed up to or later than 15 years the corresponding risks in their offspring were 2.0 ± 0.8 and 2.5 ± 0.9 %, respectively, (p = 0.9).
Using the life-table method we were not able to confirm previous findings of an increased risk of IDDM in offspring born to IDDM affected mothers younger than 25 years compared to those born to older mothers (data not shown).
The multivariate analysis of several variables that might influence the cumulative recurrence risk of diabetes in the offspring of diabetic parents was carried out separately on offspring of male and female probands all diagnosed with IDDM before offspring birth (Table 4 ). These analyses revealed that the only significant predictor of IDDM recurrence risk in offspring whose parents were diabetic before time of offspring birth was paternal age of IDDM onset, i. e. IDDM recurrence risk in paternal offspring decreased by a factor of 0.94 per year of increasing paternal age of IDDM onset (p = 0.01). In the multivar- iate analyses we found no significant influence of parental age at offspring birth, offspring current age, offspring gender or offspring birth order on the disease transmission, either in offspring of males or of females.
Discussion
The population-based data of this survey were obtained from 2726 adult Danish Caucasian IDDM patients characterised by a current age of 20±65 years and age at disease onset up to age 30 years. We found that the mean age of IDDM onset in the present proband population was significantly lower in female probands, which is in agreement with previous observations in epidemiological surveys, first in Pittsburgh, Pa., USA [24] , of a large peak at puberty, occurring approximately 1 year earlier for females. This pattern of IDDM onset has since been seen in almost all populations where registries have been established, including the Danish population [13] . The observation also agrees with recent estimations of age-and sexspecific IDDM incidence rates in Denmark [25] .
We observed a significantly decreased cumulative recurrence risk of IDDM in offspring of female probands compared to offspring of male probands, only Multivariate analysis using the cox proportional hazards model (stepwise regression) if parents had been diagnosed with IDDM before offspring birth. Despite the large size of the total offspring population, the subpopulation of offspring whose parents developed IDDM after offspring birth only comprised 14 IDDM cases. Thus, this observation needs to be confirmed in a larger population including more offspring of parents diagnosed with IDDM after offspring birth. Our findings however, suggest that genetic susceptibility to IDDM might be modified by certain aspects of diabetic pregnancies. This supports the hypothesis first proposed by Warram et al. [3] that a mechanism for this apparently protective maternal effect might be that exposure to diabetes in utero can protect a fetus from developing IDDM later in life by induction of mechanisms similar to immunological tolerance to autoantigens of beta cells. Although Warram et al. [18] in their study on self-reported data did not find a correlation between selective loss of diabetes-susceptible fetuses in perinatal deaths or spontaneous abortions and the IDDM risk in the surviving offspring, a mechanism of selective loss of genetically susceptible fetuses through early spontaneous abortions and failures in implantation in mothers with IDDM may exist. In contrast with the recent Finnish study [6] we found no sex difference in the IDDM prevalence and recurrence risk among sons and daughters of IDDM affected parents of a given sex, thus our observations are consistent with the genetic imprinting hypothesis [17] . This has to be further explored in future genetic epidemiological studies. We found that the number of offspring is significantly reduced for probands diagnosed with IDDM before having their first offspring compared to probands diagnosed after the birth of the youngest offspring. This might be due to reduced fertility in IDDM patients, IDDM complications, abortions or a voluntary choice as part of family planning. However since the IDDM recurrence risk is calculated as the number of IDDM cases per total number of offspring observation years and the potential diabetic status of an unborn offspring is notknown, the recurrence risk is unlikely to be influenced by these differences. In addition, we have restricted the multivariate analyses to the 2380 offspring whose parents were all diagnosed with IDDM before offspring birth in order to avoid a possible confounding from differences in parental IDDM status at the time of pregnancy. The finding that the offspring IDDM risk is associated with paternal age at IDDM onset partly agrees with the findings of a study from the Joslin Diabetes Clinic [5] reporting the highest IDDM recurrence risk in offspring of both fathers and mothers diagnosed with IDDM before age 11 years. However, another recent study from this clinic [4] reported in contrast to our findings that the risk among offspring of IDDM fathers did not vary according to the fathers age of diagnosis although they found that the risk in maternal offspring was only significantly lower than the risk in paternal offspring if the mothers had been diagnosed before age 8 years. The mechanisms responsible for different recurrence risks of IDDM in offspring according to age at diagnosis in parents are matters of speculation but genetic factors may play a role. It is well established that among Caucasians the HLA class II DR 3,4 phenotype is significantly more frequent in IDDM patients with early disease onset [26, 27] . None of the above-mentioned epidemiological studies were stratified for genetic components or for gender. In a recent study [28] evidence for a new IDDM susceptibility locus, IDDM15, was found. Interestingly, IDDM15 is linked to HLA in male, but not female meiosis [28] . Thus, it can be speculated that IDDM fathers with young age at onset are more likely to transmit high-risk haplotypes, e. g. including both HLA and IDDM15 high-risk alleles, to their offspring than mothers with IDDM due to linkage of non-MHC susceptibility loci to HLA.
The present study is in agreement with the findings from a recent nationwide Finnish study [6] unable to confirm earlier findings from the Joslin Diabetes Clinic [4, 5, 19] that the risk of IDDM was increased in offspring of diabetic mothers who gave birth before age 25 years compared to those who gave birth after age 25 years.
In contrast to the Finnish study [6] neither offspring gender nor offspring birth-order were significant predictors of offspring IDDM recurrence risk in our study.
In conclusion, this large Danish population-based survey confirmed previous observations that the cumulative recurrence risk of IDDM in offspring of IDDM affected mothers is significantly decreased compared to the risk in offspring of IDDM affected fathers. This difference was seen only in offspring of probands with IDDM at the time of offspring birth. However, this observation has to be confirmed in a larger population. We found that among the several biologic variables tested separately on offspring of male and female probands all diagnosed with IDDM before the time of offspring birth, paternal age at IDDM onset was the only significant predictor of IDDM recurrence risk in offspring.
The predictors of IDDM recurrence risk identified from the present population may be important for counselling families in which one parent has IDDM and should be investigated further in even larger population-based epidemiological and genetic studies.
